RACHEL GREGOROFF: Open Payments
NPI 1194274712 · ENGLEWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 31 payments from 14 companies in 2025. Trend: 2023 $867 · 2024 $932 · 2025 $632
Food & beverage: $632
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $143 |
| ABBVIE INC. | 4 | $90 |
| Janssen Biotech, Inc. | 3 | $71 |
| Ardelyx, Inc. | 3 | $60 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 3 | $40 |
| PFIZER INC. | 2 | $34 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Medtronic, Inc. | 1 | $24 |
Products named: TREMFYA, GATTEX, IBSRELA, ENTYVIO, DUPIXENT, NUCALA, VOQUEZNA, REZDIFFRA.
Industry payments across FL — which companies pay providers there.
